1urw: Difference between revisions
No edit summary |
No edit summary |
||
| Line 24: | Line 24: | ||
==Reference== | ==Reference== | ||
Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors., Byth KF, Cooper N, Culshaw JD, Heaton DW, Oakes SE, Minshull CA, Norman RA, Pauptit RA, Tucker JA, Breed J, Pannifer A, Rowsell S, Stanway JJ, Valentine AL, Thomas AP, Bioorg Med Chem Lett. 2004 May 3;14(9):2249-52. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15081018 15081018] | Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors., Byth KF, Cooper N, Culshaw JD, Heaton DW, Oakes SE, Minshull CA, Norman RA, Pauptit RA, Tucker JA, Breed J, Pannifer A, Rowsell S, Stanway JJ, Valentine AL, Thomas AP, Bioorg Med Chem Lett. 2004 May 3;14(9):2249-52. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15081018 15081018] | ||
High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design., Schulze-Gahmen U, De Bondt HL, Kim SH, J Med Chem. 1996 Nov 8;39(23):4540-6. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/8917641 8917641] | |||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
| Line 40: | Line 42: | ||
[[Category: Stanway, J J.]] | [[Category: Stanway, J J.]] | ||
[[Category: Thomas, A P.]] | [[Category: Thomas, A P.]] | ||
[[Category: Tucker, J A.]] | |||
[[Category: Valentine, A L.]] | [[Category: Valentine, A L.]] | ||
[[Category: Mitosis]] | [[Category: Mitosis]] | ||
[[Category: Serine/threonine-protein kinase]] | [[Category: Serine/threonine-protein kinase]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Sep 10 09:03:53 2008'' | ||